TY  - JOUR
AU  - Garrido-Mesa, Jose
AU  - Adams, Kate
AU  - Galvez, Julio
AU  - Garrido-Mesa, Natividad
PY  - 2022
DO  - 10.1080/13543784.2022.2054325
UR  - http://hdl.handle.net/10668/19679
T2  - Expert opinion on investigational drugs
AB  - Drug repurposing can be a successful approach to deal with the scarcity of cost-effective therapies in situations such as the COVID-19 pandemic. Tetracyclines have previously shown efficacy in preclinical acute respiratory distress syndrome (ARDS)...
LA  - en
PB  - Taylor & Francis
KW  - ARDS
KW  - COVID-19
KW  - Tetracyclines
KW  - acute respiratory distress syndrome
KW  - doxycycline
KW  - immunomodulatory
KW  - incyclinide
KW  - minocycline
KW  - repurposing
KW  - Anti-Bacterial Agents
KW  - Drug Repositioning
KW  - Humans
KW  - Pandemics
KW  - RNA, Viral
KW  - Respiratory Distress Syndrome
KW  - SARS-CoV-2
KW  - Tetracyclines
KW  - COVID-19 Drug Treatment
TI  - Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications.
TY  - research article
VL  - 31
ER  -